Abstracts tagged "ECLIPSE"

Abstract Number: 1494 • ACR/ARP Annual Meeting 2019
Guselkumab Was More Effective Than Secukinumab in Patients with Plaque Psoriasis and the Subset of Patients with Self-Reported Psoriatic Arthritis in a Randomized, Double-blind, Head-to-head Comparison Study over 1 Year
Joseph Merola¹, Shu Li ², Ming-Chun Hsu ², Chetan Karyekar ³, Susan Flavin ², Bruce Randazzo ⁴ and Laura Coates ⁵, ¹Brigham and Women's Hospital, Harvard Med School, Boston, MA, ²Janssen Research & Development, LLC, Spring House, PA, ³Janssen Global Services, LLC, Horsham, PA, ⁴Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA, ⁵University of Oxford, Oxford, United Kingdom
Background/Purpose: Guselkumab (GUS, an antibody against IL-23) and secukinumab (SEC, an antibody against IL-17A) are both approved for the treatment of psoriasis (PsO). Up to…